Skip to main content
  • Home
  • Articles
    • Archive from 2022 July
    • Archive 1960 to 2022 June
    • Accepted Articles
    • Published Ahead-of-Print
    • Supplement
  • About
  • For Authors
  • Podcasts

Respiratory precautions for MERS-CoV: acceptable risk-benefit determination

< Back to Listing

Share this Article

Singapore Med J 2014; 55(6): 293; http://dx.doi.org/10.11622/smedj.2014075
Respiratory precautions for MERS-CoV: acceptable risk-benefit determination

  • Summary
  • PDF
  • References

Hsu LY
Correspondence: Dr Hsu Li Yang, li_yang_hsu@nuhs.edu.sg

As of May 29, 2014, there have been 636 laboratoryconfirmed cases of Middle East respiratory syndrome coronavirus (MERS-CoV), with 193 deaths, which translates into a case fatality rate of 30.3%.(1) There is currently no specific treatment for the infection other than supportive medical care. The majority of recent cases appeared to arise from human-to-human transmission and have mainly occurred within the healthcare setting.(2) Although Singapore has had no MERS-CoV cases to date, we remain at continued risk for MERS-CoV importation in view of the significant number of travellers to and from the Middle East for religious (i.e. Umrah and Hajj), recreational, medical and business purposes.

Singapore Med J 2014; 55(6): 293; http://dx.doi.org/10.11622/smedj.2014075
http://smj.org.sg/sites/default/files/5506/5506ed1.pdf
REFERENCES
 
1. Australian Government Department of Health. Middle East respiratory syndrome coronavirus (MERS-CoV): situation update 29 May 2014. Available at: http://www.health.gov.au/internet/main/publishing.nsf/Content/ohp-mers-c...$file/mers-cov-situpdate-20140529.pdf.
 
2. World Health Organization. WHO risk assessment: Middle East respiratory syndrome coronavirus (MERS-CoV). Available at: http://www.who.int/csr/disease/coronavirus_infections/MERS_CoV_RA_201404....
 
3. Chung SJ, Ling ML, Seto WH, Ang BS, Tambyah PA. Debate on MERS-CoV respiratory precautions: surgical mask or N95 respirators? Singapore Med J 2014; 55:294-7.
http://dx.doi.org/10.11622/smedj.2014076
 
4. Lee HP, Wang de Y. Objective assessment of increase in breathing resistance of N95 respirators on human subjects. Ann Ocup Hyg 2011; 55:917-21.
http://dx.doi.org/10.1093/annhyg/mer065
 
5. Lim EC, Seet RC, Lee KH, et al. Headaches and the N95 face-mask amongst healthcare providers. Acta Neurol Scand 2006; 113:199-202.
http://dx.doi.org/10.1111/j.1600-0404.2005.00560.x
 
6. Foo CC, Goon AT, Leow YH, Goh CL. Adverse skin reactions to personal protective equipment against severe acute respiratory syndrome – a descriptive study in Singapore. Contact Dermatitis 2006; 55:291-4.
http://dx.doi.org/10.1111/j.1600-0536.2006.00953.x
 
7. Jefferson T, Del Mar CB, Dooley L, et al. Physical interventions to interrupt or reduce the spread of respiratory viruses. Cochrane Database Syst Rev 2011; (7):CD006207.
 
×

Around the Site

Home

About SMJ

For Reviewers

Sign Up for Alerts

Issues

Current Issue

All Issues

Online First

Supplement

CME

For Authors

Instructions for Authors

Submit Manuscript


Follow us on:
        

More Links

Contact Us

Copyright

Advertise

SMJ Forms

Privacy Policy

SMA Home

Copyright 2021. Singapore Medical Association. All Rights Reserved.